On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Eileen Farrelly

ResearcherPublications, citations & collaboration network

Eileen Farrelly is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Eileen Farrelly have?

ScholarIQindexed works

Eileen Farrelly has 91 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Eileen Farrelly have?

ScholarIQcitation count

Eileen Farrelly has 934 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Eileen Farrelly?

ScholarIQh-index

Eileen Farrelly has an h-index of 19 in OpenAlex.

What is the i10-index of Eileen Farrelly?

ScholarIQi10-index

Eileen Farrelly has an i10-index of 27 in OpenAlex.

What is the OpenAlex record for Eileen Farrelly?

ScholarIQopenalex

The OpenAlex for Eileen Farrelly is on the source record.

What are the most-cited papers on Eileen Farrelly?

ScholarIQmost cited works
Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma
Ajai Chari, Dorothy Romanus, Antonio Palumbo, Marlo Blazer, Eileen Farrelly, Aditya Raju, Hui Huang, Paul G. Richardson
Clinical Lymphoma Myeloma & Leukemia. 2019108 CitationsOPEN ACCESS
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Christoph U. Correll, Daisy Ng‐Mak, Dana Stafkey-Mailey, Eileen Farrelly, Krithika Rajagopalan, Antony Loebel
Annals of General Psychiatry. 201779 CitationsOPEN ACCESS
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States
Parameswaran Hari, Dorothy Romanus, Antonio Palumbo, Katarina Luptakova, Robert M. Rifkin, Linh Mai Tran, Aditya Raju, Eileen Farrelly, Stephen J. Noga, Marlo Blazer, Ajai Chari
Clinical Lymphoma Myeloma & Leukemia. 201843 CitationsOPEN ACCESS
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd
Ajai Chari, Paul G. Richardson, Dorothy Romanus, Meletios Α. Dimopoulos, Pieter Sonneveld, Evangelos Terpos, Roman Hájek, Aditya Raju, Antonio Palumbo, Lauren E. Cain, Marlo Blazer, Hui Huang, Eileen Farrelly, Sikander Ailawadhi
Expert Review of Hematology. 202043 CitationsOPEN ACCESS
The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims
Cindy Garris, Manan Shah, Eileen Farrelly
Cost Effectiveness and Resource Allocation. 201542 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial